ResearcherUniversity of California, San FranciscoActive in the last 2 years
Sophia Hernandez
Matched on ORCID iD 0000-0001-5763-2672; OpenAlex author ID A5043861958. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2025: 1 paper · 2026: 3 papers
Papers 4
- Re-evaluating the Role of Neoadjuvant Chemotherapy in Early-Stage Pancreatic Ductal Adenocarcinoma: Unveiling the Impact of Immortal Time Bias on Survival. Co-author DOI 10.1245/s10434-026-19829-1↗
- ASO Visual Abstract: Re-evaluating the Role of Neoadjuvant Chemotherapy in Early-Stage Pancreatic Ductal Adenocarcinoma: Unveiling the Impact of Immortal Time … Co-author DOI 10.1245/s10434-026-19921-6↗
- Survival after resection of pancreatic cancer is similar with neoadjuvant gemcitabine-nab-paclitaxel or mFOLFIRINOX but one size will not fit all in the future. Co-author DOI 10.21037/hbsn-2025-1-952↗
- Ongoing Failure to Deliver Guideline-Concordant Care for Patients with Pancreatic Cancer. Co-author DOI 10.3390/cancers17020170↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Mohamed A. Adam · 3 shared papers, 2025–2026 · strength 0.82
- Paper Re-evaluating the Role of Neoadjuvant Chemotherapy in Early-Stage Pancreatic Ductal Adenocarcinoma: Unveiling the Impac… DOI 10.1245/s10434-026-19829-1↗
- Paper ASO Visual Abstract: Re-evaluating the Role of Neoadjuvant Chemotherapy in Early-Stage Pancreatic Ductal Adenocarcinoma… DOI 10.1245/s10434-026-19921-6↗
- Paper Ongoing Failure to Deliver Guideline-Concordant Care for Patients with Pancreatic Cancer. DOI 10.3390/cancers17020170↗
- Adnan A. Alseidi · 3 shared papers, 2025–2026 · strength 0.82
- Paper Re-evaluating the Role of Neoadjuvant Chemotherapy in Early-Stage Pancreatic Ductal Adenocarcinoma: Unveiling the Impac… DOI 10.1245/s10434-026-19829-1↗
- Paper ASO Visual Abstract: Re-evaluating the Role of Neoadjuvant Chemotherapy in Early-Stage Pancreatic Ductal Adenocarcinoma… DOI 10.1245/s10434-026-19921-6↗
- Paper Ongoing Failure to Deliver Guideline-Concordant Care for Patients with Pancreatic Cancer. DOI 10.3390/cancers17020170↗
- Eric K. Nakakura · 3 shared papers, 2025–2026 · strength 0.82
- Paper Re-evaluating the Role of Neoadjuvant Chemotherapy in Early-Stage Pancreatic Ductal Adenocarcinoma: Unveiling the Impac… DOI 10.1245/s10434-026-19829-1↗
- Paper ASO Visual Abstract: Re-evaluating the Role of Neoadjuvant Chemotherapy in Early-Stage Pancreatic Ductal Adenocarcinoma… DOI 10.1245/s10434-026-19921-6↗
- Paper Ongoing Failure to Deliver Guideline-Concordant Care for Patients with Pancreatic Cancer. DOI 10.3390/cancers17020170↗
- Ajay V. Maker · 1 shared paper, 2026 · strength 0.63
- Amir Ashraf‐Ganjouei · 2 shared papers, 2025–2026 · strength 0.53
- Amir Ashraf · 1 shared paper, 2026 · strength 0.29
- Jane Wang · 1 shared paper, 2025 · strength 0.24
- J. Ejie · 1 shared paper, 2025 · strength 0.24
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.